AKEBIA THERAPEUTICS, INC. Gain (Loss) on Extinguishment of Debt
AKEBIA THERAPEUTICS, INC. (AKBA) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-02-26
- AKEBIA THERAPEUTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was $0.00.
- AKEBIA THERAPEUTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was $0.00.
- AKEBIA THERAPEUTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-06-30 was $0.00.
- AKEBIA THERAPEUTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-03-31 was $0.00.
- AKEBIA THERAPEUTICS, INC. gain (loss) on extinguishment of debt for fiscal 2025 was $0.00.
- AKEBIA THERAPEUTICS, INC. gain (loss) on extinguishment of debt for fiscal 2024 was -$517.00K.
- AKEBIA THERAPEUTICS, INC. gain (loss) on extinguishment of debt for fiscal 2023 was $0.00.
- AKEBIA THERAPEUTICS, INC. gain (loss) on extinguishment of debt for fiscal 2022 was -$906.00K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 85 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | -$517.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | -$517.00K 10-Q · filed 2025-11-10 | -$517.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | -$517.00K 10-Q · filed 2025-08-07 | -$517.00K derived: sum of 3 quarters · filed 2026-02-26 | -$517.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$517.00K 10-Q · filed 2025-05-08 | -$517.00K derived: sum of 2 quarters · filed 2026-02-26 | -$517.00K derived: sum of 3 quarters · filed 2026-02-26 | -$517.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2024-08-08 | -$906.00K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-05-09 | -$906.00K derived: sum of 3 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$906.00K derived: sum of 2 quarters · filed 2024-03-14 | -$906.00K 10-K · filed 2024-03-14 | ||
| 2022-09-30 | -$906.00K 10-Q · filed 2023-11-08 | -$906.00K 10-Q · filed 2023-11-08 | |||
| 2021-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | $0.00 derived: sum of 2 quarters · filed 2023-08-28 | $0.00 10-K/A · filed 2023-08-28 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | $0.00 10-K/A · filed 2023-08-28 | ||||
| 2014-03-31 | $3.74M 10-Q · filed 2014-05-12 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $234.00 derived: sum of 2 quarters · filed 2016-03-14 | $234.00 derived: sum of 3 quarters · filed 2016-03-14 | $2.42M 10-K · filed 2016-03-14 | |
| 2013-09-30 | $234.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $234.00 derived: sum of 2 quarters · filed 2014-11-10 | $2.42M 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $2.42M 10-Q · filed 2014-08-11 | |||
| 2013-03-31 | $2.42M 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |